Kenvue Inc. Common Stock vs NEOS S&P 500 High Income ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while NEOS S&P 500 High Income ETF trades at $54.06 (market cap $12.50B). The key difference: Kenvue Inc. Common Stock is far larger — about 2.7× NEOS S&P 500 High Income ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while NEOS S&P 500 High Income ETF pays none. Which is the better fit depends on your goals.
| KVUE | SPYI | |
|---|---|---|
Market Cap | $34.06B | $12.50B |
Volume | 23,267,228 | 3,058,962 |
Sector | Consumer Staples | Income / Options Overlay |
52-Week High | $19.83 | $54.42 |
52-Week Low | $14.11 | $47.98 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 58 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPYI trades at $54.09 with a slight 0.15% daily gain, showing modest upward momentum amid bullish technical signals. The ETF maintains a strong income focus with recent monthly dividends around $0.53-0.54, though key valuation metrics remain unavailable. Technical analysis indicates bullish moving averages but neutral oscillators, with RSI-6 suggesting potential overbought conditions at 72.22.
SPYI offers high-income generation through covered call strategies but faces principal erosion risks as highlighted in recent analysis. The ETF's 12% yield attracts retirement investors, though coverage warns of potential capital depletion with systematic withdrawals. Market sentiment remains mixed between income appeal and long-term growth concerns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →